Location History:
- Singapore, CN (2015)
- Singapore, SG (2012 - 2024)
Company Filing History:
5 out of 633 
1 out of 812 
Years Active: 2012-2025
Title: Xuewei Liu: Innovator in Pharmaceutical Science
Introduction
Xuewei Liu is a prominent inventor based in Singapore, known for his significant contributions to pharmaceutical science. With a total of five patents to his name, Liu has made remarkable strides in the field of antimicrobial research and drug formulation.
Latest Patents
Liu's latest patents include innovative compounds aimed at addressing microbial infections. One notable invention is the development of biohybrid peptidoglycan oligomers, which relate to a compound that can be used in pharmaceutical formulations for treating or detecting microbial infections. This invention also encompasses methods for determining antimicrobial resistance and effective dosing of antimicrobial agents. Another significant patent involves co-crystals of the Nuclear receptor related 1 protein-ligand binding domain (Nurr1-LBD) in complex with a cyclopentenone prostaglandin. This patent provides methods for identifying or designing Nurr1-modulating ligands, which have potential applications as medicaments.
Career Highlights
Throughout his career, Xuewei Liu has worked with esteemed institutions such as Nanyang Technological University and the National University of Singapore. His work in these organizations has allowed him to collaborate with leading researchers and contribute to groundbreaking advancements in pharmaceutical science.
Collaborations
Liu has collaborated with notable colleagues, including Ho Sup Yoon and Sreekanth Rajan. These partnerships have further enhanced his research capabilities and have led to significant innovations in his field.
Conclusion
Xuewei Liu's contributions to pharmaceutical science through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of microbial infections and drug development.